Inside informationEnglish
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 23/12/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116309_20251223